Predicting Outcomes in RA - The Role of Biomarkers

Predicting Outcomes in RA - The Role of Biomarkers is organized by Cleveland Clinic Center for Continuing Education.

Release Date: July 12, 2017
Expiration Date: July 12, 2019

Target Audience:
The online series is designed for rheumatologists, allergists/immunologists, dermatologists, internal medicine physicians, and associated allied health practitioners, including nurse practitioners, nurses, and physician assistants interested in or using biologic therapeutics for autoimmune and inflammatory disorders.

Accreditation:
The Cleveland Clinic Foundation Center for Continuing Education designates this enduring material for a maximum of 0.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Description:
Biologic Therapies VII: Precision Medicine in the Biologic Era online series brings together world leaders in immune-based therapies and addresses cutting-edge translational immunology and the latest data on biologic therapeutics.

This webcast will review several types of biomarkers, their classification criteria, the use of calprotectin, as well as MBDA scores in RA patients.

Learning Objectives:
• Distinguish between descriptive and mechanistic biomarkers.
• Identify biomarkers that predict radiographic progression among patients with rheumatoid arthritis.
• Identify biomarkers that predict response to treatment among patients with rheumatoid arthritis.

Additional details will be posted as soon as they are available.